Spring Bank Pharmaceuticals

Developer of products to treat viral infections using its small molecule nucleic acid hybrid chemistry platform

placeMilford, Massachusetts, United States calendar_todayFounded 2002 groups84 employees language springbankpharm.com

Registered entities

Innovation

12 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 548 times.

YearFilings
20123
20133
20143
20153
20166
20176
20187
20199
20201

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon